Bullous skin diseases.
Fundamental advances in the fields of molecular biology and immunology have facilitated investigation of the autoimmune blistering disorders. Recently, the use of human autoantibodies has helped to identify biologically important adhesion molecules of the skin, and the pathogenic mechanisms involved in bullous skin diseases are now being precisely defined.
Nousari
H C
HC
Johns Hopkins University, Baltimore, USA.
Anhalt
G J
GJ
D000368:Aged; D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D002450:Cell Communication; D002648:Child; D002675:Child, Preschool; D003874:Dermatitis Herpetiformis / Q000276:immunology; D004195:Disease Models, Animal; D016107:Epidermolysis Bullosa Acquisita / Q000276:immunology; D005260:Female; D006801:Humans; D007223:Infant; D015603:Keratinocytes / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008297:Male; D051379:Mice; D018448:Models, Immunological; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D012872:Skin Diseases, Vesiculobullous / Q000453:epidemiology / Q000209:etiology / Q000276:immunology*
D001323:Autoantibodies